Drug:
Reaction: PRURITUS
20250101 - 20251231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 25133400 |
US |
68 | 1 |
Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 102 | 25133410 |
US |
2 | |
Urticaria, Headache, Pruritus, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 103 | 25133424 |
US |
2 | |
Pruritus, |
||||
CETIRIZINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, EPINEPHRINE, ADRENALINUM, FAMOTIDINE, METHYLPREDNISOLONE, MONTELUKAST, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PHENTERMINE HYDROCHLORIDE, TRANEXAMIC ACID, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 104 | 25133501 |
MX |
41 | 1 |
Burning sensation, Pruritus, Throat irritation, |
||||
OCRELIZUMAB, |
||||
| 105 | 25133551 |
CA |
||
White blood cell count increased, Rheumatic fever, X-ray abnormal, Lung disorder, Laryngitis, Grip strength, Pneumonia, Visual impairment, Stomatitis, Weight increased, Joint range of motion decreased, Bone erosion, Irritable bowel syndrome, Lupus-like syndrome, Systemic lupus erythematosus, Muscle injury, Impaired healing, Dyspnoea, Hepatic enzyme increased, Abdominal pain upper, Headache, Oedema, Loss of personal independence in daily activities, Dizziness, Night sweats, Weight fluctuation, Swollen joint count increased, Pancreatitis, Rectal haemorrhage, Rheumatoid arthritis, Decreased appetite, Obesity, Laboratory test abnormal, Weight decreased, Diarrhoea, Gait disturbance, Glossodynia, Hand deformity, Exostosis, Mobility decreased, Liver disorder, Musculoskeletal stiffness, Sciatica, General physical health deterioration, Adjustment disorder with depressed mood, Depression, Arthritis, Facet joint syndrome, Insomnia, Lip dry, Vomiting, Discomfort, Hepatic cirrhosis, Folliculitis, Inflammation, Pyrexia, Liver injury, Autoimmune disorder, Anti-cyclic citrullinated peptide antibody positive, Peripheral swelling, Oedema peripheral, Pain, Fibromyalgia, Wound, Hypoaesthesia, Condition aggravated, Gastrointestinal disorder, Nasopharyngitis, Feeling hot, Memory impairment, Delirium, Swollen joint count, Breast cancer stage III, Asthma, Porphyria acute, Paraesthesia, Foot deformity, Wheezing, Synovitis, Ill-defined disorder, Arthralgia, Dry mouth, Crohn^s disease, Muscle spasms, Muscular weakness, Rash, Chest pain, Contusion, Infusion related reaction, Peripheral venous disease, Rheumatoid factor positive, Duodenal ulcer perforation, Migraine, Abdominal discomfort, Hypertension, Osteoarthritis, Sinusitis, Pruritus, Grip strength decreased, Asthenia, Type 2 diabetes mellitus, Fatigue, Musculoskeletal pain, Sleep disorder due to general medical condition, insomnia type, Pemphigus, Sleep disorder due to a general medical condition, Abdominal pain, Pulmonary fibrosis, C-reactive protein abnormal, Blood cholesterol increased, Hypersensitivity, Nausea, Joint swelling, Arthropathy, Swelling, Blister, Walking aid user, Drug hypersensitivity, Amnesia, Retinitis, Bursitis, Osteoporosis, Anxiety, Dyspepsia, Frequent bowel movements, Urticaria, Hypercholesterolaemia, Injury, Colitis ulcerative, Psoriatic arthropathy, Malaise, Lupus vulgaris, Confusional state, Dislocation of vertebra, Road traffic accident, Alopecia, Pericarditis, Infection, Ear infection, Lower respiratory tract infection, Wound infection, Helicobacter infection, Maternal exposure during pregnancy, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, SECUKINUMAB, SECUKINUMAB, RAMIPRIL, LISINOPRIL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ERYTHROMYCIN, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ALBUTEROL SULFATE, ALBUTEROL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, HYDROXYCHLOROQUINE SULFATE, LANSOPRAZOLE, ERGOCALCIFEROL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, TOCILIZUMAB, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, APREMILAST, APREMILAST, APREMILAST, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, PREGABALIN, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, PREGABALIN, HYALURONIDASE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, LEFLUNOMIDE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DESOXIMETASONE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LORAZEPAM, FLUOROMETHOLONE, SULFASALAZINE, SULFASALAZINE, QUETIAPINE FUMARATE, QUETIAPINE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, MESALAMINE, TOFACITINIB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LISINOPRIL, RITUXIMAB, RITUXIMAB, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, CAFFEINE, MELOXICAM, MORPHINE, MAGNESIUM, USTEKINUMAB, TOFACITINIB, TOFACITINIB, DOXYCYCLINE, DOXYCYCLINE HYCLATE, LANSOPRAZOLE, INFLIXIMAB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, CALCIUM CARBONATE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, HYDROXYCHLOROQUINE SULFATE, SECUKINUMAB, |
||||
| 106 | 25133632 |
GB |
41 | 2 |
Swelling face, Angioedema, Lip swelling, Lethargy, Pruritus, Insomnia, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 107 | 25133723 |
CA |
64 | 2 |
Anxiety, Ear swelling, Flushing, Hypersensitivity, Hypertension, Pruritus, Restlessness, Tachycardia, Urticaria, |
||||
| 108 | 25133913 |
US |
59 | 2 |
Stress, Swollen tongue, Lacrimation increased, Visual impairment, Pain, Tongue biting, Oropharyngeal pain, Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 109 | 25133919 |
US |
62 | 2 |
Pruritus, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 110 | 25133923 |
US |
32 | 1 |
Rash erythematous, Pruritus, Skin burning sensation, Condition aggravated, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 111 | 25133925 |
US |
47 | 1 |
Influenza, Pruritus, |
||||
DUPILUMAB, |
||||
| 112 | 25133936 |
US |
59 | 1 |
Rash pruritic, Product dose omission issue, Pruritus, |
||||
DUPILUMAB, |
||||
| 113 | 25133956 |
US |
91 | 2 |
Arthritis, Pruritus, Rebound effect, Skin burning sensation, Skin wrinkling, |
||||
DUPILUMAB, PREDNISONE, CETIRIZINE HYDROCHLORIDE, |
||||
| 114 | 25133957 |
US |
19 | 2 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 115 | 25133994 |
US |
1 | |
Pruritus, |
||||
DUPILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 116 | 25133996 |
US |
||
Condition aggravated, Pruritus, |
||||
DUPILUMAB, |
||||
| 117 | 25133998 |
US |
12 | 1 |
Dermatitis allergic, Condition aggravated, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 118 | 25134002 |
US |
55 | 2 |
Cheilitis, Drug hypersensitivity, Lip dry, Dry skin, Pruritus, Dry eye, Eye irritation, Dermatitis atopic, Condition aggravated, Rash, |
||||
DUPILUMAB, |
||||
| 119 | 25134009 |
US |
18 | 2 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, ERGOCALCIFEROL, MAGNESIUM, PAROXETINE HYDROCHLORIDE, |
||||
| 120 | 25134043 |
US |
59 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 121 | 25134100 |
US |
44 | 1 |
Dry skin, Paraesthesia, Pruritus, Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 122 | 25134207 |
US |
2 | |
Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 123 | 25134400 |
US |
||
Pruritus, |
||||
OCRELIZUMAB, |
||||
| 124 | 25134448 |
US |
23 | 1 |
Sleep disorder due to a general medical condition, Pruritus, Therapeutic response decreased, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, MOMETASONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, OLOPATADINE, |
||||
| 125 | 25134569 |
US |
79 | 2 |
Vulvovaginal pain, Gait disturbance, Eating disorder, Vulvovaginal burning sensation, Swelling, Abdominal pain, Pruritus, Product use in unapproved indication, |
||||
NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 126 | 25134664 |
CN |
68 | 1 |
Temperature intolerance, Chills, Rash, Pruritus, |
||||
ALBUMIN HUMAN, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, |
||||
| 127 | 25134761 |
US |
2 | |
Rash, Product use issue, Pruritus, |
||||
PEMBROLIZUMAB, LENVATINIB, LEVOTHYROXINE SODIUM, ERGOCALCIFEROL, CODEINE PHOSPHATE AND GUAIFENESIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM, POLYETHYLENE GLYCOL 3350, MONTELUKAST SODIUM, CETIRIZINE HYDROCHLORIDE, FAMOTIDINE, |
||||
| 128 | 25134876 |
DE |
68 | 1 |
Dysstasia, Ill-defined disorder, Sensory disturbance, Dizziness, Alopecia, Dry skin, Pruritus, |
||||
CARBOPLATIN, ATEZOLIZUMAB, ETOPOSIDE, |
||||
| 129 | 25134937 |
CA |
||
Surgery, Pruritus, Therapeutic product effect incomplete, |
||||
FAMOTIDINE, OMALIZUMAB, MONTELUKAST SODIUM, MONTELUKAST, |
||||
| 130 | 25134945 |
US |
72 | 1 |
Pruritus, Inappropriate schedule of product administration, Incorrect dose administered, Wrong technique in product usage process, |
||||
DUPILUMAB, |
||||
| 131 | 25134978 |
GB |
74 | 2 |
Osteoporosis, Gastrooesophageal reflux disease, Feeling cold, Pruritus, Malaise, Incorrect dose administered, |
||||
| 132 | 25135063 |
US |
78 | 2 |
Pruritus, |
||||
PALBOCICLIB, |
||||
| 133 | 25135154 |
CA |
||
Asthenia, Flatulence, Loss of personal independence in daily activities, Urticaria, Pruritus, Arthralgia, Injection site rash, Injection site pruritus, Diarrhoea, Diarrhoea, Incorrect dose administered, Device malfunction, Device use error, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, PREDNISONE, COLESEVELAM HYDROCHLORIDE, |
||||
| 134 | 25135205 |
JP |
||
Urticaria, Pruritus, Treatment noncompliance, |
||||
OSIMERTINIB, |
||||
| 135 | 25135218 |
US |
19 | 2 |
Pruritus, Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 136 | 25135232 |
PT |
39 | 2 |
Pruritus, Pruritus, |
||||
OXALIPLATIN, |
||||
| 137 | 25135262 |
US |
72 | 1 |
IgA nephropathy, Pruritus, Therapeutic response decreased, |
||||
DUPILUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 138 | 25135285 |
CN |
7 | 1 |
Contrast media allergy, Blood pressure decreased, Pruritus, Heart rate increased, |
||||
GADOBUTROL, |
||||
| 139 | 25135337 |
US |
65 | 2 |
Pruritus, Dermatitis, |
||||
DUPILUMAB, |
||||
| 140 | 25135373 |
US |
83 | 1 |
Seizure, Hypoxia, Upper respiratory tract infection, Rhinitis, Pulmonary mass, Cough, Pain, Burning sensation, Decreased appetite, Dyspnoea, Pruritus, Insomnia, Diarrhoea, |
||||
DUPILUMAB, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 141 | 25135378 |
US |
22 | 1 |
Eczema, Pruritus, |
||||
DUPILUMAB, |
||||
| 142 | 25135400 |
US |
48 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 143 | 25135644 |
CN |
58 | 1 |
Mouth ulceration, Dermatitis acneiform, Pruritus, Disease progression, |
||||
BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, AFATINIB, ACARBOSE, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, CISPLATIN, CISPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 144 | 25135740 |
CN |
38 | 1 |
Rash, Pruritus, Nausea, Off label use, |
||||
CYTARABINE, CYTARABINE, |
||||
| 145 | 25135765 |
US |
1 | |
Pruritus, Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 146 | 25135923 |
US |
49 | 2 |
Injection site swelling, Pruritus, Peripheral swelling, Pain in extremity, Rheumatoid arthritis, |
||||
TOCILIZUMAB-AAZG, |
||||
| 147 | 25135967 |
CA |
42 | 2 |
Mammogram abnormal, Pruritus, Oral herpes, |
||||
GOLIMUMAB, |
||||
| 148 | 25136070 |
46 | 2 | |
Burning sensation, Pain, Infusion related reaction, Pruritus, Product quality issue, |
||||
| 149 | 25136102 |
CN |
16 | 1 |
Discomfort, Urticaria, Swelling, Dyspnoea, Pruritus, Hypertension, Drug hypersensitivity, Expired product administered, |
||||
| 150 | 25136174 |
FR |
48 | 2 |
Neutropenia, Thrombocytopenia, Skin toxicity, Anaemia, Pruritus, Off label use, Adverse drug reaction, |
||||
AMIVANTAMAB, AMIVANTAMAB, AMIVANTAMAB, |
||||
| 151 | 25136227 |
US |
68 | 1 |
Pruritus, Erythema, Administration site discolouration, |
||||
NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, METOPROLOL TARTRATE, METOPROLOL, HYDROXYZINE, AMLODIPINE, SPIRONOLACTONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FAMOTIDINE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, FUROSEMIDE, ISOSORBIDE MONONITRATE, TICAGRELOR, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, AZELASTINE, FLUTICASONE PROPIONATE, METHYLPREDNISOLONE, |
||||
| 152 | 25136260 |
PT |
65 | 2 |
Demyelinating polyneuropathy, Allodynia, Constipation, Abdominal distension, Pruritus, Skin burning sensation, Hypoglycaemia, Blood glucose increased, |
||||
INSULIN DEGLUDEC, INSULIN ASPART, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 153 | 25136294 |
US |
74 | 2 |
Swelling face, Lip swelling, Pruritus, Rash erythematous, Off label use, |
||||
IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10%, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 154 | 25136332 |
US |
61 | 1 |
Dysphagia, Arthropod bite, Condition aggravated, Skin swelling, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 155 | 25136507 |
US |
78 | 2 |
Pruritus, Off label use, |
||||
| 156 | 25136539 |
CN |
29 | 2 |
Shock, Pruritus, |
||||
| 157 | 25136623 |
55 | 1 | |
Diarrhoea, Pruritus, Rash, Urticaria, Vomiting, Abdominal discomfort, Nausea, |
||||
TIRZEPATIDE, |
||||
| 158 | 25136628 |
US |
2 | |
Skin weeping, Skin haemorrhage, Condition aggravated, Pruritus, Injection site pain, Drug ineffective, |
||||
DUPILUMAB, LATANOPROST, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ZOLPIDEM TARTRATE, LEVOTHYROXINE SODIUM, AMOXICILLIN, AMLODIPINE BESYLATE, FUROSEMIDE, |
||||
| 159 | 25136640 |
US |
1 | |
Inflammatory bowel disease, Joint swelling, Blood creatinine increased, White blood cell count decreased, Injection site mass, Product dose omission issue, Product use issue, Injection site pain, Injection site erythema, Insomnia, Pruritus, |
||||
TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, INFLIXIMAB-DYYB, |
||||
| 160 | 25136648 |
US |
85 | 2 |
Rash, Pruritus, |
||||
ALBUMIN HUMAN, |
||||
| 161 | 25136705 |
CA |
57 | 2 |
Dysaesthesia, Fatigue, Joint stiffness, Mouth ulceration, Muscular weakness, Neuropathy peripheral, Pruritus, Rash maculo-papular, Malignant neoplasm progression, Papillary cystadenoma lymphomatosum, Toxicity to various agents, Off label use, |
||||
PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FOLIC ACID, FOLIC ACID, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 162 | 25136933 |
US |
||
Hepatotoxicity, Pruritus, |
||||
RESMETIROM, FLUCONAZOLE, |
||||
| 163 | 25136950 |
US |
||
Hepatic cirrhosis, Pruritus, |
||||
RESMETIROM, |
||||
| 164 | 25137001 |
US |
46 | 2 |
Deep vein thrombosis, Anaemia, Intracranial pressure increased, Deep vein thrombosis, Constipation, Pruritus, Arthralgia, Hepatic steatosis, Aspartate aminotransferase increased, Acute sinusitis, |
||||
MIRIKIZUMAB-MRKZ, OXYCODONE, FERROUS SULFATE, FERROUS SULFATE, MELATONIN, ASCORBIC ACID, PREDNISONE, NALTREXONE, GABAPENTIN, BUPROPION HYDROCHLORIDE, BUPROPION, IPRATROPIUM BROMIDE AND ALBUTEROL, TOPIRAMATE, TOPIRAMATE SPINKLE, MESALAMINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 165 | 25137059 |
US |
65 | 1 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 166 | 25140613 |
61 | 2 | |
Rash erythematous, Pruritus, Pain, Hypoaesthesia, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, VITAMIN C, FISH OIL, |
||||
| 167 | 25126268 |
US |
25 | 1 |
Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 168 | 25126273 |
US |
27 | 2 |
Dermatitis atopic, Rash, Pruritus, Intentional product misuse, |
||||
DUPILUMAB, |
||||
| 169 | 25126294 |
US |
63 | 1 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 170 | 25126356 |
US |
1 | |
Skin exfoliation, Pruritus, Dry skin, |
||||
DUPILUMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ORAL SEMAGLUTIDE, DAPAGLIFLOZIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, GLIMEPIRIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 171 | 25126442 |
CA |
63 | 1 |
Blood triglycerides increased, Drug interaction, Malignant neoplasm of eye, Off label use, Pruritus, Insomnia, Anxiety, Therapeutic response shortened, |
||||
CITALOPRAM, CITALOPRAM HYDROBROMIDE, ABROCITINIB, ABROCITINIB, ABROCITINIB, |
||||
| 172 | 25126887 |
US |
||
Pain in extremity, Back pain, Chest pain, Eructation, Nausea, Pruritus, Urticaria, Lip swelling, |
||||
| 173 | 25126955 |
US |
61 | 2 |
Pruritus, Therapeutic product effect incomplete, |
||||
BIMEKIZUMAB, |
||||
| 174 | 25127024 |
US |
2 | |
Pruritus, Product dose omission issue, |
||||
BIMEKIZUMAB, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, CELECOXIB, |
||||
| 175 | 25127035 |
US |
60 | 1 |
Pain, Erythema, Pruritus, Burning sensation, |
||||
BIMEKIZUMAB, |
||||
| 176 | 25127036 |
US |
1 | |
Pruritus, Inappropriate schedule of product administration, |
||||
BIMEKIZUMAB, |
||||
| 177 | 25127040 |
US |
53 | 2 |
Nausea, Diarrhoea, Pruritus, |
||||
BIMEKIZUMAB, |
||||
| 178 | 25127128 |
US |
78 | 1 |
Erythema, Pruritus, Pain, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 179 | 25127175 |
US |
2 | |
Pruritus, |
||||
BIMEKIZUMAB, |
||||
| 180 | 25127187 |
US |
34 | 2 |
Pain, Erythema, Pruritus, |
||||
BIMEKIZUMAB, |
||||
| 181 | 25127254 |
US |
2 | |
Product dose omission issue, Pruritus, |
||||
BIMEKIZUMAB, |
||||
| 182 | 25127272 |
CA |
63 | 2 |
Abdominal pain, Pruritus, Flushing, Dyspnoea, Hallucination, visual, Rash, Urticaria, |
||||
CISPLATIN, DIPHENHYDRAMINE HYDROCHLORIDE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, MONTELUKAST, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, RANITIDINE, |
||||
| 183 | 25127328 |
CA |
||
Surgery, Muscle twitching, Throat irritation, Flushing, Pruritus, Off label use, |
||||
RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE SODIUM SUCCINATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 184 | 25127668 |
US |
41 | 1 |
Pruritus, Dermatitis atopic, |
||||
TRALOKINUMAB-LDRM, |
||||
| 185 | 25127850 |
AU |
62 | 1 |
Anaphylactic reaction, Pruritus, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 186 | 25127960 |
CA |
44 | 2 |
Alopecia, Blister, Drug intolerance, Hepatic enzyme increased, Hypersensitivity, Impaired healing, Joint swelling, Musculoskeletal stiffness, Pruritus, Rash, Sinusitis, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Weight increased, Wound, Rheumatoid arthritis, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 187 | 25128036 |
US |
72 | 1 |
Rash, Pruritus, |
||||
LENALIDOMIDE, |
||||
| 188 | 25128061 |
US |
70 | 1 |
Product dose omission issue, Pruritus, Rash, Dry skin, |
||||
LENALIDOMIDE, |
||||
| 189 | 25128679 |
US |
29 | 2 |
Erythema, Condition aggravated, Pruritus, Skin burning sensation, Condition aggravated, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 190 | 25128684 |
US |
9 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 191 | 25128686 |
US |
84 | 1 |
Sleep disorder due to a general medical condition, Purpura, Feeling hot, Nasopharyngitis, Pruritus, Rash, |
||||
DUPILUMAB, ACYCLOVIR, SULFAMETHOXAZOLE AND TRIMETHOPRIM, APIXABAN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 192 | 25128694 |
US |
1 | |
Pruritus, |
||||
DUPILUMAB, |
||||
| 193 | 25128710 |
US |
1 | 1 |
Dry skin, Sleep disorder, Pruritus, Therapeutic response decreased, Dry eye, Eye irritation, Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 194 | 25128745 |
US |
41 | 2 |
Skin swelling, Condition aggravated, Erythema, Condition aggravated, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 195 | 25128764 |
US |
54 | 1 |
Rash erythematous, Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 196 | 25128765 |
US |
20 | 1 |
Erythema, Condition aggravated, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 197 | 25128806 |
US |
78 | 1 |
Dry skin, Skin fissures, Sleep disorder due to a general medical condition, Pruritus, |
||||
DUPILUMAB, |
||||
| 198 | 25128838 |
US |
2 | |
Dermatitis, Pruritus, Skin exfoliation, Dry skin, |
||||
DUPILUMAB, ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE, BACLOFEN, ETANERCEPT, HYDROXYZINE, LINACLOTIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, |
||||
| 199 | 25128843 |
US |
58 | 2 |
Blister, Pain of skin, Pruritus, Rash, |
||||
DUPILUMAB, |
||||
| 200 | 25128852 |
US |
48 | 2 |
Dry skin, Pruritus, Dry eye, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28